Newsroom

Inflammatix Checks off All the Right Boxes with Investors

Mar 19, 2021

Inflammatix nets $102M to advance its immune system tests for infectious diseases

Mar 16, 2021

Infection-detection system from Peninsula company scores $102M, aims to hit market this year

Mar 16, 2021

A Bright Future Ahead for Novel Markers of Infection

Dec 15, 2020

Inflammatix Awarded $7.4M in Additional BARDA Funding for POC System, Acute Infection Test

Oct 29, 2020

Inflammatix Moving Into Coronavirus Test Market With Gene Expression Host Response Platform

Oct 8, 2020

Machine Learning-Based Rapid Diagnostic Reads Immune System to Predict COVID-19 Severity Risk

Sep 30, 2020

Three Predictions For Healthcare Platforms

Sep 8, 2020

20 medical device startups you need to know

Jun 26, 2020

MedTech Innovator Announces Top 50 Medtech Startups Selected for Annual Showcase and Accelerator

Jun 22, 2020

The Battle for a Better Sepsis Test

Apr 1, 2020

Stanford alumni founders tackle COVID-19 with StartX task force

Mar 19, 2020

Inflammatix collects $57M as it awaits FDA review of infectious disease test

Sep 12, 2024

Targeting FDA OK for its test against deadly sepsis, South Bay company raises $57 million

Sep 12, 2024

Rapid Tests Continue Push Into Sepsis Market in 2023 as Competition Heats Up

Jan 2, 2024

Inflammatix sepsis test scores FDA breakthrough device designation

Nov 28, 2023

Inflammatix Aims for 2024 Launch of 30-Minute Sepsis and Acute Infection Test

Nov 28, 2023

Your medical devices are getting smarter. Can the FDA keep them safe?

Oct 9, 2023

Point-of-care testing for infectious diseases in emergency settings

Jan 18, 2023

Do Your Genes Know What’s Making You Sick?

Jan 6, 2022

Artificial Intelligence for Clinical Decision Support in Sepsis

May 13, 2021